PMC7768567_01
CTA demonstrated a 140-mm rAAA, with aortocaval fistula.
10.1177_2050313X20984322-fig1.jpg
PMC7768567_01_10.1177_2050313X20984322-fig1.jpg
fig1-2050313X20984322
PMC7768567_02
PMC7768567_03
Bilirubin levels during the hospitalization.. Note that the parallel levels increase. Hemolysis increased only indirect
bilirubin.
10.1177_2050313X20984322-fig2.jpg
PMC7768567_05_10.1177_2050313X20984322-fig2.jpg
fig2-2050313X20984322
The contemporary therapy of CVVH and CytoSorb continued for 4 days and determined a significant decrease in bilirubin levels (Figure 2), with improvement in urine output.
PMC7768567_04
CTA identified perfusion of the aneurysm sac caused by type III endoleak with
flow into the inferior cava vein through the aortocaval fistula.
10.1177_2050313X20984322-fig3.jpg
PMC7768567_04_10.1177_2050313X20984322-fig3.jpg
fig3-2050313X20984322
PMC7768567_05
Bilirubin levels during the hospitalization.. Note that the parallel levels increase. Hemolysis increased only indirect
bilirubin.
10.1177_2050313X20984322-fig2.jpg
PMC7768567_05_10.1177_2050313X20984322-fig2.jpg
fig2-2050313X20984322
The contemporary therapy of CVVH and CytoSorb continued for 4 days and determined a significant decrease in bilirubin levels (Figure 2), with improvement in urine output.
Deployment of Nellix catheter and the filling with polymer of the bags.
10.1177_2050313X20984322-fig4.jpg
PMC7768567_05_10.1177_2050313X20984322-fig4.jpg
fig4-2050313X20984322
CA, USA) were advanced into the previous endograft; deployment of Nellix catheter and the filling with polymer of the bags were performed (Figure 4). Complete angiography showed the complete resolution of the endoleak.